Rocket One Q2 net loss widens 74.4% to USD 3.84 million - RKTO News | RalliesRocket One Q2 net loss widens 74.4% to USD 3.84 million
R
RKTO• Q2 loss widens as R&D and G&A rise
- Rocket One posted a Q2 net loss of USD 3.84 million, or USD 0.19 per share, versus a USD 2.2 million loss.
- R&D spending climbed to USD 1.96 million from USD 1.04 million, driven mainly by HT-001 manufacturing and clinical activities.
- G&A costs rose 62% to USD 1.88 million, largely on higher stock-based compensation tied to stock option issuances.
- Cash and cash equivalents totaled USD 7.89 million at June 30, 2026; net cash used in operations was USD 6.02 million.
- Strategy shifted toward AI infrastructure and next-generation semiconductors, while continuing development of Hoth Therapeutics drug candidates.
PHOE
•
